CLEARVIEW CINEMA GROUP INC
10QSB, 1997-11-14
MOTION PICTURE THEATERS
Previous: AFFINITY GROUP HOLDING INC, 10-Q, 1997-11-14
Next: TRAVEL SERVICES INTERNATIONAL INC, 10-Q, 1997-11-14






                               UNITED STATES
                     SECURITIES AND EXCHANGE COMMISSION
                           WASHINGTON, D.C. 20549

                                FORM 10-QSB



       /X/     QUARTERLY REPORT UNDER SECTION 13 or 15(d) OF THE SECURITIES
               EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER
               30, 1997



       / /     TRANSITION REPORT UNDER SECTION 13 or 15 (d) OF THE
               SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD 
               FROM        TO
                    ------    -------
                             



Commission file number  001-13187
                        ---------

                         CLEARVIEW CINEMA GROUP, INC.
      (Exact name of small business issuer as specified in its charter)

                Delaware                               22-3338356
    (State or other jurisdiction of                 (I.R.S. employer
     incorporation or organization)                identification no.)

                               7 Waverly Place
                          Madison, New Jersey 07940
                   (Address of principal executive offices)

                                (201) 377-4646
               (Issuer's telephone number, including area code)

      Check  whether the issuer:  (1) filed all reports  required to be filed by
Section 13 or 15(d) of the  Exchange  Act during the past 12 months (or for such
shorter period that the  registrant was required to file such reports),  and (2)
has been subject to such filing requirements for the past 90 days. Yes No x

APPLICABLE ONLY TO CORPORATE ISSUERS:

      State the number of shares  outstanding of each of the issuer's classes of
common equity,  as of the latest  practicable  date:  2,108,800 shares of common
stock were outstanding as of November 10, 1997

Transitional Small Business Disclosure Format (check one):  Yes /  /   No / x /

<PAGE>

                        PART I - FINANCIAL INFORMATION

ITEM 1.     FINANCIAL STATEMENTS

                CLEARVIEW CINEMA GROUP, INC. AND SUBSIDIARIES

                         CONSOLIDATED BALANCE SHEETS

<TABLE>
<CAPTION>
                                                     DECEMBER 31,     SEPTEMBER 30,
                                                        1996            1997
                                                        ----            ----
                                                                     (UNAUDITED)

              ASSETS
 CURRENT ASSETS:
    <S>                                              <C>             <C>  
     Cash                                            $   751,345     $ 1,195,712
     Inventories                                          45,102          78,236
     Other current assets                                 34,866         321,365
                                                     -----------     -----------
        Total current assets                             831,313       1,595,313
                                                                      

PROPERTY AND EQUIPMENT, LESS  ACCUMULATED
  DEPRECIATION                                        11,412,217      21,072,010
                                                     -----------     -----------
OTHER ASSETS:
     Intangible assets, less accumulated
       amortization                                    2,711,518       3,360,478
     Project acquisition costs                           434,326         144,809
     Escrow deposits                                     294,529         294,529
     Security deposits and other assets                   76,641          86,676
                                                     -----------     -----------
                                                       3,517,014       3,886,492
                                                     ===========     ===========
                                                     $15,760,544     $26,553,815

</TABLE>

See accompanying notes to consolidated financial statements.


                                       2
<PAGE>



                CLEARVIEW CINEMA GROUP, INC. AND SUBSIDIARIES

                     CONSOLIDATED BALANCE SHEETS (CONT'D)


<TABLE>
<CAPTION>
                                                              DECEMBER 31,       SEPTEMBER 30,
                                                                 1996                1997
                                                                 ----                 ----
                                                                                 (UNAUDITED)
<S>                                                           <C>               <C>
 LIABILITIES AND STOCKHOLDERS'
    EQUITY (DEFICIENCY)
 CURRENT LIABILITIES:
      Current maturities of long-term debt                     $    835,650    $  1,317,696
      Current maturities of subordinated notes
        payable:
         Related parties                                            479,986         491,046
      Accounts payable and accrued expenses                       1,226,502       1,936,235
                                                               ------------    ------------
          Total current liabilities                               2,542,138       3,744,977
                                                               ------------    ------------
 LONG-TERM LIABILITIES:
      Long-term debt, less current maturities                     7,742,611      12,770,454
      Subordinated notes payable, less current
        maturities:
         Related parties                                            593,882         599,530
         Other                                                      600,000            --
                                                               ------------    ------------
                                                                  8,936,493      13,369,984
                                                               ------------    ------------
 COMMITMENTS AND CONTINGENCIES

 REDEEMABLE PREFERRED STOCK AT
    REDEMPTION PRICE                                              2,132,294            --
                                                               ------------    ------------

 REDEEMABLE COMMON STOCK AT
    REDEMPTION PRICE
                                                                    357,305            --
                                                               ------------    ------------

 STOCKHOLDERS' EQUITY (DEFICIENCY):
      Undesignated Preferred Stock:
         Authorized 2,498,697 shares,
           issued and outstanding - none                                 --              --
      Class A Preferred Stock, par value $.01,
        authorized 1,303 shares;
        outstanding 779 shares                                            8               8
      Common Stock, par value $.01, authorized
        10,000,000 shares; outstanding 832,800
        and 2,108,800 shares, respectively                            8,328          21,088
       Additional paid-in capital                                 4,827,096      11,012,433
      Accumulated deficit                                          (553,519)     (1,594,675)
      Less: Redemption price of redeemable stock                 (2,489,599)           --
                                                               ------------    ------------
         Total stockholders' equity (deficiency)                  1,792,314       9,438,854
                                                               ------------    ------------
                                                               $ 15,760,544    $ 26,553,815
                                                               ============    ============
</TABLE>

See accompanying notes to consolidated financial statements.

                                       3

<PAGE>


                CLEARVIEW CINEMA GROUP, INC. AND SUBSIDIARIES

                    CONSOLIDATED STATEMENTS OF OPERATIONS
                                 (UNAUDITED)

<TABLE>
<CAPTION>
                                                   THREE MONTHS ENDED
                                                   ------------------
                                          SEPTEMBER 30,           SEPTEMBER  30,
                                          -------------           ------------
                                      1996           1997              1997
                                      ----           ----              ----
                                                                     PRO FORMA
                                                                      (Note 4)
<S>                                <C>           <C>             <C> 
THEATER REVENUES:
  Box office                       $ 2,199,327    $ 3,335,958    $ 4,213,950
  Concession                           692,755        976,966      1,225,631
  Other                                 55,701        129,193         75,450
                                   -----------    -----------    -----------
                                     2,947,783      4,442,117      5,515,031
                                   -----------    -----------    -----------
OPERATING EXPENSES:
   Film rental and booking fees      1,075,741      1,669,935      2,060,312
   Cost of concession sales             99,210        146,325        188,820
   Theater operating expenses        1,207,784      1,706,986      2,090,247
   General and administrative          181,136        242,071        385,438
expenses
   Depreciation and amortization       233,514        569,027        660,858
                                   -----------    -----------    -----------
                                     2,797,385      4,334,344      5,385,675
                                   -----------    -----------    -----------

OPERATING INCOME (LOSS)                150,398        107,773        129,356

INTEREST EXPENSE                       202,288        525,230        503,838
                                   -----------    -----------    -----------

NET LOSS                           $   (51,890)   $  (417,457)   $  (374,482)
                                     ==========      ==========   =========== 
                                    

WEIGHTED AVERAGE COMMON SHARES

   SHARES AND EQUIVALENTS
   OUTSTANDING
                                     1,797,000       1,443,000       2,489,000
                                     =========       =========       =========
                                   
                  
 NET LOSS PER COMMON SHARE               $ (.03)        $ (.30)         $ (.16)
                                         ======         ======         ======= 
</TABLE>
                                                        
  
See accompanying notes to consolidated financial statements.

                                       4


<PAGE>



                CLEARVIEW CINEMA GROUP, INC. AND SUBSIDIARIES

                    CONSOLIDATED STATEMENTS OF OPERATIONS
                                 (UNAUDITED)

<TABLE>
<CAPTION>
                                                 NINE MONTHS ENDED
                                           SEPTEMBER  30,        SEPTEMBER 30,
                                        
                                        1996           1997            1997
                                      ----------      -------        ------
                                                                     PRO FORMA
                                                                      (NOTE 4)
<S>                                <C>              <C>            <C>  
THEATER REVENUES:
  Box office                       $  4,050,390    $  8,044,812    $ 10,644,032
  Concession                          1,243,711       2,314,787       3,073,713
  Other                                  75,026         270,328         314,431
                                   ------------    ------------    ------------
                                      5,369,127      10,629,927      14,032,176
                                   ------------    ------------    ------------

OPERATING EXPENSES:
   Film rental and booking fees       1,928,100       3,858,635       5,026,096
   Cost of concession sales             186,429         367,603         493,655
   Theater operating expenses         2,231,021       4,155,946       5,443,509
   General and administrative
       expenses                         408,736         646,789         827,361
   Depreciation and amortization        375,420       1,366,734       1,651,734

                                      5,129,706      10,395,707      13,442,355
                                   ------------    ------------    ------------

OPERATING INCOME                        239,421         234,220         589,821

INTEREST EXPENSE                        372,352       1,249,376       1,368,101
                                   ------------    ------------    ------------

NET LOSS                           $   (132,931)   $ (1,015,156)   $   (778,280)
                                   ============    ============    ============

WEIGHTED AVERAGE COMMON SHARES
   SHARES AND EQUIVALENTS
   OUTSTANDING                        1,797,000       1,668,000       2,650,000
                                      =========       =========       =========

 NET LOSS PER COMMON SHARE         $       (.07)   $       (.62)   $       (.30)
                                   ============    ============    ============
</TABLE>

See accompanying notes to consolidated financial statements.


                                       5
<PAGE>


                CLEARVIEW CINEMA GROUP, INC. AND SUBSIDIARIES

          CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY

                     NINE MONTHS ENDED SEPTEMBER 30, 1997
                                 (UNAUDITED)

<TABLE>
<CAPTION>

 
                                                                                        ADDITIONAL
                                   PREFERRED STOCK                COMMON STOCK            PAID-IN         ACCUMULATED
                                  SHARES      AMOUNT            SHARES     AMOUNT         CAPITAL           DEFICIT
                                 ------      ------            ------     ------         -------           -------
<S>                               <C>          <C>             <C>         <C>        <C>            <C>
BALANCES, JANUARY 1, 1997         779           $ 8           832,800     $ 8,328     $ 4,827,096      $ (553,519)

NINE MONTHS ENDED
SEPTEMBER 30, 1997:
  Repurchase of
   warrants held by
   lender                                                                              (1,000,000)
  Purchase of
   underwriter warrants                                                                     1,000
    
  Issuance of common
   stock:
     At initial
      public offering,
      net of costs                   -            -         1,150,000       11,500      7,055,597

     Upon termination of
     preferred stock
       redemption right
       considered a
       preferred stock  
       dividend                     -             -             60,000         600         25,400         (26,000)
   In exchange for
       warrants surrendered         -             -             66,000         660        103,340
Net loss                            -             -               -              -              -       (1,015,156)
                                   ---           ----        ---------   ---------   ------------       ---------- 
 BALANCES, SEPTEMBER 30, 1997      779           $  8        2,108,800    $ 21,088   $ 11,012,433       (1,594,675)
                                   ===           =====       =========    =========   ============       ========== 

</TABLE>

See accompanying notes to consolidated financial statements.
 
                                      6

<PAGE>


                CLEARVIEW CINEMA GROUP, INC. AND SUBSIDIARIES
                    CONSOLIDATED STATEMENTS OF CASH FLOWS
                                  (UNAUDITED)

<TABLE>
<CAPTION>

                                                                      NINE MONTHS ENDED
                                                                         SEPTEMBER 30,
                                                                    1996             1997
                                                                    -----            ----
<S>                                                             <C>             <C>    
 CASH FLOWS FROM OPERATING ACTIVITIES:
     Net loss                                                   $   (132,931)   $ (1,015,156)  
     Adjustments to reconcile net loss to net                   
       cash flows from operating activities:                         
          Depreciation and amortization                                375,420       1,366,734                                
          Amortization of debt discount                                 22,382         126,463                 
          Common stock issued upon surrender of                                                
             warrants, recorded as interest expense                       --           104,000   
     Changes in operating assets and liabilities:                    
         Inventories                                                   (22,986)        (33,134)  
         Other current assets                                          (39,942)       (286,499)                                     
         Security deposits and other assets                            (43,088)        (10,035)
         Accounts payable and accrued liabilities                      516,186         709,733                 
             Net cash flows from operating activities                  675,041         962,106                                 
                                                                  ------------    ------------      
 CASH FLOWS FROM INVESTING ACTIVITIES:                                                         
      Purchase of property and equipment                            (144,823)     (2,208,255) 
      Purchase of property and equipment upon                      
         acquisition  of theaters                                  (6,290,000)     (8,475,070)  
      Purchase of intangible assets                                  (627,963)       (229,679) 
                                                                     --------        --------  
           Net cash flows from investing activities                (7,062,786)    (10,913,004)  
                                                                  ------------    ------------    
                                                            
 CASH FLOW FROM FINANCING ACTIVITIES:                       
      Proceeds from long-term debt                                  4,293,775       4,824,738   
      Payments on long-term debt                                      (11,543)       (424,604)  
      Payments on subordinated notes payable, other                      --          (600,000)  
      Proceeds from issuance of preferred stock                      2,500,000            --     
      Proceeds from issuance of common stock                            70,000            --     
      Payments on option                                              (120,000)           --     
      Proceeds from initial public offering                              --         9,200,000   
      Proceeds from sale of underwriter warrants                         --             1,000   
      Costs related to issuance of preferred stock                    (154,911)           --              
      Debt issuance costs                                             (203,581)      (472,966)  
      Costs related to initial public offering                                     (2,132,903)  
      Dividends paid                                                  (10,000)           --     
                                                                   ------------  ------------   
              Net cash flows from financing                                               
                 activities                                          6,363,740     10,395,265   
                                                                  ------------    -----------   
 NET CHANGE IN CASH                                                    (24,005)       444,367   
 CASH, BEGINNING OF PERIOD                                             176,203        751,345   
                                                                  ------------   ------------   
 CASH, END OF PERIOD                                              $    152,198   $  1,195,712   
                                                                  ============    ============   
</TABLE>                                                          
                                                                   
See accompanying notes to consolidated financial statements 

                                       7

<PAGE>



                CLEARVIEW CINEMA GROUP, INC. AND SUBSIDIARIES

                    CONSOLIDATED STATEMENTS OF CASH FLOWS
                                 (UNAUDITED)

<TABLE>
<CAPTION>

                                                    NINE MONTHS ENDED SEPTEMBER 30,
                                                         1996             1997
                                                         ----             ----
<S>                                                    <C>             <C>    

SUPPLEMENTAL CASH FLOW INFORMATION: 

Interest paid                                          $  204,619     $  968,373
                                                       ==========     ==========
Income taxes paid                                      $    1,871     $    4,560
                                                       ==========     ==========
Non-cash investing and financing
   activities:

       Conversion of subordinated note
           payable - related party
           into common stock                           $   80,000     $     --
                                                       ----------     ----------
      Common stock issued for purchase
           of assets                                   $ 1,110,00     $     --   
                                                       ----------     ----------
      Warrants repurchased through
           issuance of debt                            $     --       $1,000,000
                                                       ----------     ----------

      Common stock issued upon
           termination of preferred stock
           redemption right,considered
           a preferred stock dividend                  $     --       $   26,000
                                                       ----------     ----------

</TABLE>


See accompanying notes to consolidated financial statements.

                                       8

<PAGE>

                CLEARVIEW CINEMA GROUP, INC. AND SUBSIDIARIES

                  NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


NOTE 1--BASIS OF PRESENTATION:

      The balance  sheet at December  31, 1996 has been derived from the audited
balance  sheet  contained in the  Registration  Statement on Form SB-2 (File No.
333-27819),  as amended (the "Form SB-2") of Clearview Cinema Group,  Inc. (the
"Company"),  which became  effective on August 12,  1997,  and is presented  for
comparative  purposes.  All other  financial  statements are  unaudited.  In the
opinion of  management,  all  adjustments,  which include only normal  recurring
adjustments  necessary  to present  fairly the  financial  position,  results of
operations  and cash  flows  for all  periods  presented,  have been made in the
interim   statements.   Results  of  operations  for  interim  periods  are  not
necessarily indicative of the operating results for a full year.

      Footnote disclosures normally included in financial statements prepared in
accordance with generally  accepted  accounting  principles have been omitted in
accordance  with the  published  rules and  regulations  of the  Securities  and
Exchange  Commission.  The financial statements in this report should be read in
conjunction with the financial statements and notes thereto included in the Form
SB-2.

NOTE 2--STOCKHOLDERS' EQUITY:

      STOCK SPLIT - In May 1997, the Company's Board of Directors approved a 600
to 1 stock split which was  subsequently  effected  in August  1997.  Such stock
split  has  been  retroactively  reflected  in  the  accompanying   consolidated
financial statements.

      INITIAL PUBLIC OFFERING - On August 22, 1997, the Company's initial public
offering (the  "Offering") was  consummated,  pursuant to which the Company sold
1,000,000 shares of its common stock, $.01 par value (the "Common Stock"). Gross
proceeds totaled $8.0 million and net proceeds to the Company, after expenses of
the Offering totaled  approximately  $6.0 million.  Subsequently,  the Company's
underwriters   exercised  their   over-allotment   option  to  purchase  150,000
additional  shares  of  Common  Stock,  resulting  in  additional  gross and net
proceeds to the Company of $1.2 million and $1.074 million, respectively.

      REDEMPTION RIGHTS - A certain common stockholder had the right to sell its
shares of Common Stock, to the Company for a 30-day period commencing in 2002 at
a redemption  price based upon a formula.  If such  stockholder did not exercise
that right,  the Company had the right to purchase  those shares of Common Stock
from such  stockholder for the 90-day period  commencing after the expiration of
that 30-day period at a price based upon the same formula.  Such stockholder and
the Company  terminated  those  rights upon  consummation  of the  Offering.  In
addition,  concurrently  with  the  consummation  of the  Offering,  holders  of
warrants to purchase  97,500 shares of Common Stock (at exercise  prices ranging
from $3.33 to $6.67 per share) 


                                    9
<PAGE>

exchanged  such  warrants for 66,000 shares of Common stock and also amended the
terms of certain  subordinated notes payable. The fair value of the Common Stock
issued, less the value of the warrants and rights  surrendered,  was recorded as
interest expense of $104,000 upon consummation of the Offering.

      The holder of the outstanding  shares of the Company's Class A Convertible
Preferred Stock, $.01 par value (the "Class A Preferred Stock"),  had the right,
exercisable on or after June 1, 2001, to sell to the Company all of those shares
or the shares of Common  Stock into which those  shares had been  converted at a
redemption price determined in accordance with a specified formula.  Such holder
terminated  that right upon  consummation  of the  Offering in exchange  for the
issuance of 60,000 shares of Common  Stock.  The fair value of the 60,000 shares
of  Common  Stock  issued,  less the  estimated  value of the  redemption  right
terminated, was recorded as a preferred stock dividend.

      The Company had reported this redeemable  stock at the current  redemption
value separately between liabilities and stockholders'  equity, since redemption
was outside of the  Company's  control.  A  corresponding  reduction was made to
stockholders'  equity,  as the  equivalent  of  treasury  stock.  The per  share
redemption  value of the Class A  Preferred  Stock was based on the  greater  of
gross revenues (as defined) or six times theater  operating  income (as defined)
before general and administrative expenses, interest and taxes for the preceding
twelve months  divided by the number of shares of Common Stock issued and, as if
converted  or  exercised,  all  convertible  securities,  options,  warrants and
similar instruments.  The redemption value of the Common Stock was based on book
value per share computed on a fully diluted basis.

      The  termination of these two redemption  rights upon  consummation of the
Offering resulted in a reclassification  of the respective  redemption values to
stockholders' equity.

NOTE 3--CREDIT AGREEMENT:

      The Company entered into the an amended and restated credit agreement (the
"Credit  Facility")  with The Provident  Bank on September 12, 1997.  The Credit
Facility  consists of a $1.0  million  revolving  credit  facility,  a term loan
facility of $14.0 million used to refinance existing term loans of $10.4 million
and for $3.6  million  of new term  loans of  which  $2.15  million  was used to
finance  part of the  purchase  price for five  theaters  acquired  from  United
Artists Theatre Circuit, Inc. ("United Artists"), and a term loan facility of up
to $15.0 million to finance future capital  expenditures and  acquisitions.  The
interest  rate on all loans  under the Credit  Facility  is 1/2% to 1% over that
lender's prime rate depending upon  maintenance of certain  financial  ratios of
the Company.  Principal is payable  quarterly and interest is payable monthly in
arrears.  The final maturity of all term loans will be on the fifth  anniversary
of the Credit Facility.  The loans under the Credit Facility are  collateralized
by substantially all of the assets of the Company and its subsidiaries.

                                       10
<PAGE>


NOTE 4--ACQUIRED THEATERS

      On September  12, 1997,  the Company  completed  the  acquisition  of five
theaters  from United  Artists (the "UA  Acquisition")  for a purchase  price of
$8.65 million in cash, which was provided by the proceeds of the Offering and by
borrowings under the Credit Facility.  The completion of this transaction raised
the Company's total number of theaters to 22 and its screen count to 83.

      The unaudited pro forma results of operations included in this report have
been prepared as if the Company's 1996 and 1997 acquisitions  occurred as of the
beginning of the respective periods after giving effect to certain  adjustments,
including  increased  depreciation  expense and  increased  interest  expense on
acquisition  debt.  The pro forma results have been  prepared for  informational
purposes only and do not purport to indicate the results of operations  (i) that
actually would have occurred had the acquisitions  been consummated on the dates
indicated  or (ii)  that may  occur in the  future.  The pro  forma  results  of
operations  (unaudited)  for the nine and three months ended  September 30, 1997
are  presented on the face of the  Statements of  Operations,  together with the
respective historical results of operations.

      Unaudited  condensed pro forma  results of operations  for the nine months
ended September 30, 1996 are summarized below:

                                           SEPTEMBER 30, 1996
                                             (UNAUDITED)

            Revenues                      $ 13,608,502
            Net loss                      $   (680,554)
            Net loss per share            $       (.25)


NOTE 5--SUBSEQUENT EVENTS

      The Company  purchased the leasehold of the Roslyn Trio Theater in Roslyn,
New York, a three screen cinema  theater,  in November 1997. The Company is also
planning  to acquire  two  multiplex  theaters  with 22  screens  located in New
Jersey.  The Company continues to pursue the acquisition of additional  theaters
in the New York metropolitan area and other demographically suitable locations.

                                     11
<PAGE>

ITEM 2.     MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATIONS

      THE  FOLLOWING  DISCUSSION  AND  ANALYSIS  OF  THE  COMPANY'S  RESULTS  OF
OPERATIONS  AND  FINANCIAL  CONDITION  SHOULD  BE READ IN  CONJUNCTION  WITH THE
INFORMATION  SET FORTH IN THE UNAUDITED  FINANCIAL  STATEMENTS AND NOTES THERETO
INCLUDED  ELSEWHERE  HEREIN AND THE AUDITED  FINANCIAL  STATEMENTS AND THE NOTES
THERETO INCLUDED IN THE SB-2, WHICH BECAME EFFECTIVE ON AUGUST 12, 1997.

 
OVERVIEW

      The Company has achieved  significant growth in theaters and screens since
its formation in December 1994.  From inception,  when the Company  acquired the
right to operate four theaters with eight screens,  through  September 30, 1997,
the Company has  acquired  the right to operate 18 theaters  with 69 screens and
has added six screens to two existing  theaters.  In November  1997, the Company
also acquired a three screen theater in Roslyn,  New York.  The Company  expects
that its future revenue  growth will be derived  primarily from the operation of
additional  theaters,  the  development  of new theaters  and adding  screens to
existing theaters. The Company has had no theater closings since inception.

      The  Company's  revenues  are  predominantly  generated  from  box  office
receipts,  concession  sales and  on-screen  advertising.  Direct  theater costs
include film rental and booking fees and the cost of concessions.  Other theater
operating expenses consist primarily of theater labor and related fringe benefit
costs and occupancy costs  (including rent and/or real estate taxes,  utilities,
repairs and  maintenance,  cleaning costs and  supplies).  Film rental costs are
directly  related to the  popularity of a film and the length of time since that
film's  release.  Film rental costs  generally  decline as a  percentage  of box
office receipts the longer a film has been showing. As certain concession items,
such as fountain  drinks and popcorn,  are purchased in bulk and not prepackaged
for individual  servings,  the Company has  significant  gross profit margins on
those items.

      General  and  administrative   expenses  consist  primarily  of  corporate
overhead  costs,  such as  management  and office  salaries  and related  fringe
benefits costs,  professional fees, insurance costs and general office expenses.
The  Company  believes  that  its  current  internal   controls  and  management
information  system  will  allow the  Company  to expand  its  number of screens
without  incurring   proportionate   increases  in  general  and  administrative
expenses.

      In  September  1995,  the  Company  acquired  the right to  operate  three
theaters with 11 screens in Nassau County, New York in an all-cash  transaction.
In May 1996,  the Company  purchased  the  leaseholds  of four  theaters with 19
screens in New York and New Jersey for a combination  of stock and cash. In July
1996,  Clearview  purchased the leaseholds of two theaters with seven screens in
Westchester County, New York for cash. In December 1996,  Clearview acquired two
more  theaters  with the  underlying  real estate and the  leasehold  of another
theater with a total of 13 screens in Bergen  County,  New Jersey.  In September
1997,  Clearview  completed the UA Acquisition  and acquired three theaters with
the underlying real estate and the leaseholds of two additional theaters.  These
five theaters (the "UA Theaters")  have a total of 14 screens and are located in
Wayne, New Jersey and Bronxville,  Larchmont, Mamaroneck and New City, New York.
The total  purchase  price of $8.65  million  was paid  using  proceeds  of $6.5
million  from the  Offering  and  financing  of $2.15  million  from the  Credit
Facility.


                                       12
<PAGE>


COMPARATIVE QUARTERLY RESULTS

      TOTAL  REVENUES.  Total  revenues  for the nine  and  three  months  ended
September 30, 1997 were $10,629,927 and $4,442,117 respectively,  as compared to
$5,369,127  and  $2,947,783  for the nine and three months ended  September  30,
1996, respectively.  The increases in revenues of 98.0% and 50.7%, respectively,
are principally attributable to an increase in attendance to 1,494,860 attendees
in the nine months ended  September 30, 1997 from 776,815  attendees in the nine
months  ended  September  30,  1996,  and an increase in  attendance  to 603,307
attendees in the three months ended September 30, 1997 from 429,194 attendees in
the three months ended  September 30, 1996. The increase in attendance  occurred
principally because of the addition of 39 screens during 1996.

      FILM RENTAL AND BOOKING  FEES.  Film rental and booking fees  increased by
100.1% and 55.2% to  $3,858,635  and  $1,669,935  for the nine and three  months
ended September 30, 1997,  respectively,  from $1,928,100 and $1,075,741 for the
nine and three months ended September 30, 1996, respectively. As a percentage of
box office  receipts,  film  rentals  and  booking  fees were 48.0% for the nine
months ended  September  30, 1997 as compared to 47.6% for the nine months ended
September 30, 1996.  Such costs were 50.1% of box office  receipts for the three
months ended  September 30, 1997, as compared to 48.9% for the same 1996 period.
See "Operating Income" below for additional information.

      COST OF CONCESSION  SALES. Cost of concession sales increased by 97.2% and
47.5% to $367,603 and $146,325 for the nine and three months ended September 30,
1997,  respectively,  from  $186,429  and $99,210 for the nine and three  months
ended September 30, 1996,  respectively.  The increase in the cost of concession
sales occurred  principally  because of the addition of 39 screens in 1996. As a
percentage of concession  revenues,  the cost of concession sales were 15.9% and
15.0% for the nine and three months  ended  September  30,  1997,  respectively,
compared to 15.0% and 14.3% for the nine and three  months ended  September  30,
1996, respectively.

      THEATER OPERATING EXPENSES.  Theater operating expenses increased by 86.3%
and 41.3% to  $4,155,946  and  $1,706,986  for the nine and three  months  ended
September 30, 1997,  respectively,  from  $2,231,021 and $1,207,784 for the nine
and three  months  ended  September  30, 1996,  respectively.  This  increase is
attributable  solely to the nine theaters  acquired in 1996, which  acquisitions
occurred  during the second,  third and fourth quarters of 1996. As a percentage
of total revenues,  theater operating  expenses decreased to 39.1% and 38.4% for
the nine and three months ended  September 30, 1997,  respectively,  compared to
41.6%  and  41.0%  for the nine and  three  months  ended  September  30,  1996,
respectively. The decrease for the nine and three month periods, as a percentage
of total revenues, is primarily due to the Company's efficient management of its
variable costs and the lower average  per-theater fixed costs, such as occupancy
costs, taxes and common area maintenance costs, of the theaters acquired in 1996
as compared to the Company's other theaters.

      GENERAL AND ADMINISTRATIVE EXPENSES.   General and administrative expenses
increased  by 58.2% and 33.6% to $646,789  and  $242,071  for the nine and three
months ended  September 30,


                                       13
<PAGE>

1997,  respectively,  from  $408,736  and $181,136 for the nine and three months
ended September 30, 1996,  respectively.  The increase is due principally to the
hiring of  additional  personnel and  increases in salaries  resulting  from the
transition  from seven  locations  and 21 screens at the beginning of 1996 to 16
locations  and 60 screens at the  beginning of 1997.  As a  percentage  of total
revenues,  however,  general and  administrative  expenses decreased to 6.1% and
5.4% for the nine and three months ended September 30, 1997, respectively,  from
7.6%  and  6.1%  for the  nine  and  three  months  ended  September  30,  1996,
respectively.  The decrease, as a percentage of total revenues, is due primarily
to the Company's  internal  controls and management  information  system,  which
allowed  the  Company  to  expand  its  number  of  screens  without   incurring
proportionate increases in general and administrative expenses.

      DEPRECIATION  AND  AMORTIZATION.  Depreciation  and  amortization  expense
increased by 264.1% and 143.7% to $1,366,734 and $569,027 for the nine and three
months ended  September 30, 1997,  respectively,  from $375,420 and $233,514 for
the nine and three months ended September 30, 1996,  respectively.  The increase
was primarily a result of the  acquisition of the nine theaters  acquired in the
second,  third and fourth quarters of 1996,  which  significantly  increased the
Company's depreciable and amortizable assets.

      OPERATING  INCOME.  Operating   income  decreased  by  2.2%  and  28.3% to
$234,220 and $107,773  for the nine and three months ended  September  30, 1997,
respectively,  from  $239,421  and  $150,398 for the nine and three months ended
September 30, 1996, respectively.  As a percentage of total revenues,  operating
income was 2.2% and 2.4% for the nine and three months ended  September 30, 1997
and  4.5% and 5.1% for the nine and  three  months  ended  September  30,  1996,
respectively.   The   fluctuations   were  primarily  due  to  the  increase  in
depreciation  and amortization  expense  discussed above, as well as a result of
the films available for exhibition  during the three-month  period and six-month
period ended  September  30, 1997. 

      As discussed  above,  film rental and booking fees (as a percentage of box
office  receipts)  for the three months ended  September  30, 1997  increased to
50.1% from 48.9% in the similar 1996 period.  Such increase in costs and related
decrease in operating  income is attributable to the selection of films released
during the third  quarter of 1997. A number of films  released  during the third
quarter of 1997  experienced  successful  opening  weekends  but were  unable to
sustain the popularity  necessary to generate  significant  box office  receipts
thereafter.  As film  exhibitors  incur much  greater  film  rental fees for the
opening  weeks of a film's  release when compared to the fees incurred for later
weeks,  this trend resulted in the increase in film cost for the Company and the
entire motion picture exhibition industry. See also the discussion of "Quarterly
Results and Seasonality" below.

      INTEREST  EXPENSE.  Interest  expense  increased  by 235.5%  and 159.6% to
$1,249,376 and $525,230 for the nine and three months ended  September 30, 1997,
respectively,  from  $372,352  and  $202,288 for the nine and three months ended
September  30,  1996,  respectively.   The  increase  was  attributable  to  the
significant  increase in the Company's  total debt during the second,  third and
fourth  quarters of 1996,  which was primarily  incurred in connection  with the
Company's acquisitions during that year. Interest expense also includes non-cash
charges for  amortization  of debt discount of $126,463 and $38,814 for the nine
and three  months  ended  September  30,  1997


                                       14
<PAGE>

and $22,382  and  $15,360  for the  comparable  1996  periods,  and  $104,000 in
connection with the surrender of warrants during the quarter ended September 30,
1997.

      NET LOSS.  Net loss  increased to $1,015,156 and $417,457 for the nine and
three months ended September 30, 1997, respectively, from net losses of $132,931
and  $51,890  for  the  nine  and  three  months  ended   September   30,  1996,
respectively.  The increase in the net loss was  primarily a result of the films
available for exhibition  during the two periods,  as discussed  above,  and the
increased  1997  depreciation,  amortization  and  interest  expenses due to the
effect of the inclusion of the 1996 acquisitions for a full year.

LIQUIDITY AND CAPITAL RESOURCES

      The Company  derives  substantially  all of its  revenues  from box office
receipts and  concession  sales and,  therefore,  benefits from the fact that it
has, in effect, no accounts receivable and minimal inventory  requirements.  The
Company's most significant operating expenses, film rental and booking fees, are
not typically paid to distributors  until 30 to 45 days following the receipt of
the applicable cash ticket  payments.  In addition,  most of the Company's other
operating expenses, such as theater payroll and theater rent, are paid bi-weekly
or  monthly,  respectively.  The  periods  between  the  receipt  of  cash  from
operations  and use of that cash to pay the  related  expenses  provide  certain
operating capital to the Company.

      Since  the  Company  is  in  an  industry  which  is  capital   intensive,
substantially  all of its assets are non-current.  The Company's primary current
asset is cash,  while  inventories are relatively  insignificant  throughout the
fiscal year. The Company had negative working capital of $2,149,664 at September
30, 1997. The Company has current  maturities of long-term debt at September 30,
1997 of  $1,317,696,  which  it  expects to  satisfy  from its  cash  flow  from
operations over the next twelve months.

      The  Company  has   historically   financed  its   day-to-day   operations
principally from the cash flow generated by its operating activities.  Such cash
flow from  operations  totaled  $962,106 for the nine months ended September 30,
1997,  as compared  to $675,041  for the similar  1996  period.  The  difference
between the  Company's net loss and its cash flow from  operating  activities is
principally  due to the  Company's  depreciation  and  amortization  expenses of
$1,366,734  for the nine months  ended  September  30, 1997 and $375,420 for the
similar  1996  period,  amortization  of debt  discount of $126,463 for the nine
months  ended  September  30, 1997 and  $22,382 for the similar  1996 period and
interest  expense  recorded  upon  surrender  of  certain  warrants  in  1997 of
$104,000,  all of which are non-cash expenses. The Company's cash flow generated
by its operating activities was $424,580 and $224,878 for the three months ended
September 30, 1997 and 1996, respectively.  The difference between the Company's
net  income or loss and its cash flow from  operating  activities  for the three
months ended  September  30, 1997 and 1996 is  principally  due to the Company's
depreciation  and  amortization  expenses of $569,027 and $233,514 for the three
months ended  September 30, 1997 and 1996,  respectively,  amortization  of debt
discount  of $38,814  and  $15,360  for the same  three  month  periods  and the
interest  expense  of  $104,000  referred  to above,  all of which are  non-cash
expenses.


                                       15
<PAGE>


      The  Company's  capital  requirements  during  1997 arose  principally  in
connection  with the  renovation of existing  theaters,  the  development of new
theaters  and the  addition  of screens to an  existing  theater.  Such  capital
expenditures    were   financed    principally    with   bank   borrowings   and
internally-generated   cash.   Capital   expenditures,   exclusive   of  theater
acquisitions, totaled approximately $2.2 million during the first nine months of
1997.  The  Company  financed  its 1997  acquisition  and  capital  expenditures
principally   from  the  net  proceeds  of  the  Offering  and  additional  bank
borrowings. During 1996, the Company funded its capital expenditures,  including
theater  acquisitions,  through  approximately  $4.3 million of bank borrowings,
$5.0 million of seller-provided  financing,  $2.5 million of gross proceeds from
the sale of shares of Class A Preferred Stock and $1.1 million from the issuance
of shares of Common  Stock to the seller of a  theater.  In  January  1997,  the
Company retired $4.4 million of that  seller-provided  financing with additional
bank borrowings and $100,000 in cash.

      The Company seeks to lease theaters rather than to purchase  theaters with
their  underlying  real  estate or to purchase  properties  for  development  as
theaters due to the  significantly  lower capital  requirements  for leasing and
because it believes  that its  potential  return on  investment  when  leasing a
theater  is  higher  than its  potential  return on  investment  if it owns that
theater and the underlying real estate.

      The Company anticipates that its capital  expenditures in 1997,  including
acquisitions,  will be approximately $25.0 million. Of this amount, $500,000 was
used to add four  screens to the  Company's  theater  in  Chester,  New  Jersey,
$900,000 was used to convert a part of a building into a theater in Summit,  New
Jersey, and $8.65 million was used to consummate the UA Acquisition.

      INITIAL PUBLIC OFFERING.  On August 22, 1997, the Offering was consummated
and the Company sold 1,000,000  shares of Common Stock.  Gross proceeds  totaled
$8.0 million and net proceeds to the Company,  after  expenses of the  Offering,
totaled  approximately $6.0 million.  Subsequently,  the Company's  underwriters
exercised their  over-allotment  option to purchase 150,000 additional shares of
Common Stock,  resulting in additional  gross and net proceeds to the Company of
$1.2 million and $1.074 million, respectively.

      CREDIT AGREEMENT. The Credit Facility consists of a $1.0 million revolving
credit  facility,  a term  loan  facility  of $14.0  million  used to  refinance
existing  term loans of $10.4  million and for $3.6 million of new term loans of
which $2.15  million  was used to finance  part of the  purchase  price for five
theaters  acquired from United Artists,  and a term loan facility of up to $15.0
million to finance future capital  expenditures and  acquisitions.  The interest
rate on all loans  under the Credit  Facility  is 1/2% to 1% over that  lender's
prime rate depending upon the  maintenance  of certain  financial  ratios of the
Company.  Principal  is payable  quarterly  and  interest is payable  monthly in
arrears.  The final maturity of all term loans will be on the fifth  anniversary
of the Credit Facility.  The loans under the Credit Facility are  collateralized
by substantially all of the assets of the Company and its subsidiaries.

      ACQUIRED  THEATERS.  The purchase price for the UA  Acquisition  was $8.65
million,  which was paid with $6.5  million in proceeds  from the  Offering  and
$2.15  in  borrowings  under  the  


                                       16
<PAGE>

Credit Facility. The completion of the UA Acquisition raised the Company's total
number of theaters to 22 and its screen count to 83.

QUARTERLY RESULTS AND SEASONALITY

            Historically,  the most  successful  films have been released during
the summer  months  (July and August)  and  Thanksgiving  through  the  year-end
holiday  season.  Consequently,  motion  picture  exhibitors  generally have had
proportionality  higher  revenues during such periods,  although  seasonality of
motion picture exhibition revenues has become less pronounced in recent years as
studios have begun to release major motion  pictures more evenly  throughout the
year.  The  Company  believes  that its  regular  exhibition  of art  films  has
contributed  to a moderation in the  seasonality of its own revenues as compared
to the seasonality of the revenues of some of its competitors.  Nevertheless the
Company's  revenues and income in any particular  quarter will be  substantially
the result of the  commercial  success of the particular  films being  exhibited
during such quarter.

EFFECTS OF INFLATION

      Inflation has not had a significant impact on the Company's  operations to
date.



                                       17
<PAGE>




                         PART II - OTHER INFORMATION


ITEM 2.     CHANGES IN SECURITIES AND USE OF PROCEEDS

      The registration  statement on Form SB-2 (File No. 333-27819)  relating to
the public offering of up to 1,150,000 shares of Common Stock was filed with the
Securities  and Exchange  Commission  pursuant to the Securities Act of 1933, as
amended,  on May 27, 1997 and amended on July 18, 1997,  August 4, 1997,  August
11, 1997, and August 12, 1997 (the "Registration  Statement").  The Registration
Statement was declared  effective by the Securities  and Exchange  Commission on
August 12, 1997.  The Offering  commenced on August 19, 1997 and  terminated  on
September  15, 1997,  after the sale of all  1,150,000  shares.  One hundred and
fifty thousand shares were purchased from the Company by its  underwriters,  for
whom Prime  Charter Ltd.  ("Prime  Charter")  was acting as the  representative,
solely for the purpose of covering over-allotments.

      The gross proceeds of the Offering were $9,200,000.  The expenses incurred
in connection with the Offering totaled $2,132,903. Of that amount, $736,000 for
discounts and commissions and another $276,940 for additional  expenses was paid
to Prime Charter. Other Offering expenses, including but not limited to expenses
for professional fees, printing fees and filing fees, totaled $1,119,163.

      The net  proceeds of the  Offering,  after  deducting  the expenses of the
Offering were  $7,067,097  (the "Net Offering  Proceeds").  A portion of the Net
Offering  Proceeds  was used to  retire a Senior  Subordinated  Note  (principal
amount  $600,000)  issued by the Company to Magic  Cinemas  LLC on December  13,
1996.  The remaining  $6,467,097  was used to pay a  substantial  portion of the
$8.65 million purchase price for the UA Theaters.

      The use of the  proceeds of the  Offering by the Company is in  accordance
with  the  description  of the  use of  proceeds  appearing  on  page  13 of the
prospectus included in the Registration Statement.

ITEM 6.     EXHIBITS AND REPORTS ON FORM 8-K.

      The following exhibits are attached hereto or incorporated by reference as
part of this report.

Exhibit   Description                                        Method of Filing

11.01     Statement re: computation of per share earnings    Filed herewith
27.01     Financial Data Schedule                            Filed herewith

      No reports on Form 8-K were filed by the  Company  during  this  reporting
period.


                                       18
<PAGE>


                                  SIGNATURES

      In accordance with the  requirements of the Securities and Exchange Act of
1934, as amended, the registrant has duly caused this report to be signed on its
behalf by the undersigned thereunto duly authorized.


                                          CLEARVIEW CINEMA GROUP, INC.



      November 13, 1997                  /s/ A. Dale Mayo 
                                         -------------------------------------
                                          A. Dale Mayo
                                          Chairman of the Board, President and
                                             Chief Executive Officer



      November 13, 1997                  /s/ Joan M. Romine
                                         -------------------------------------
                                         Joan M. Romine
                                         Treasurer and Chief Financial Officer
                                         (Chief Accounting Officer)


                                       19
<PAGE>




                                EXHIBIT INDEX


Exhibit   Description                                        Method of Filing

11.01     Statement re: computation of per share earnings    Filed herewith
27.01     Financial Data Schedule                            Filed herewith




                                       20




                                                                   EXHIBIT 11.01

                    Statement Regarding Earnings per Share

A summary of Shares of Common Stock and  equivalents  treated as outstanding for
the  purposes  of  calculating  net income  (loss) per Common  Share for periods
reported herein is as follows:

<TABLE>
<CAPTION>

QUARTER ENDED SETPTEMBER 30, 1997:                                 WEIGHTED
- ---------------------------------                                 ---------
<S>                                                <C>               <C>

Shares of Common Stock outstanding                    832,800        832,800

Shares  issued  upon consummation  of 
  initial  public  offering  and  related
  concurrent transactions and Underwriters' 
  exercise of overallotment option                  1,276,000        610,261
                                                    ---------        -------



                                                    2,108,800      1,443,061
                                                    ---------      ---------


FROM JANUARY 1 THROUGH JUNE 30, 1997:
- -------------------------------------

Shares of Common Stock outstanding                    832,800

Shares of common Stock issuable upon:  (1)

      Conversion of 779 shares of Class A
        Preferred Stock                               467,400

      Exercise of Warrants -

         200 A/B Warrants                             120,000

         157 Provident Warrants (2)                    94,200

         Class A Warrants                             282,600
                                                      -------
                                                    1,797,000
                                                    ---------
</TABLE>

<PAGE>

<TABLE>
<CAPTION>


WEIGHTED SHARES OUTSTANDING SUMMARY  
FOR NINE MONTHS ENDED                                    WEIGHT
SEPTEMBER 30, 1997                           SHARES      (DAYS)      WEIGHTED
- ------------------                           ------      ------      --------
<S>                                       <C>          <C>          <C>  
January 1 through June 30, 1997           1,797,000       181       1,191,418

Quarter Ended September 30, 1997          1,443,061        92         486,306
                                                          ---      ----------
                                                       273 Days     1,677,724
                                                       --------     ---------

</TABLE>

<TABLE>
<CAPTION>
                                                           PERIOD ENDED
                                                        SEPTEMBER 30, 1997
                                                  NINE MONTHS       THREE MONTHS
<S>                                              <C>                <C> 
Net loss                                         $(1,015,156)       $  (417,457)

Less: Preferred stock dividend                       (26,000)           (26,000)
                                                 -----------        -----------
Net loss attributable to common
  shareholders                                   $(1,041,156)       $  (443,457)

Weighted shares outstanding                        1,678,000          1,443,000
                                                 -----------        -----------
Loss per common share                            $      (.62)       $      (.30)
                                                 -----------        -----------

(1)  Reference should be made to the Company's accounting policy as disclosed in
     the  consolidated  financial  statements  included  in Form SB-2.  Weighted
     shares  outstanding  for the quarters prior to the initial public  offering
     are  calculated  in  accordance  with  the  rules  and  regulations  of the
     Securities and Exchange Commission.  Weighted shares outstanding subsequent
     to June 30, 1997 are calculated in accordance with APB 15.

(2)  Such warrants were repurchased by the Company on June 30, 1997.

</TABLE>


<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
THIS  SCHEDULE  CONTAINS  SUMMARY  FINANCIAL   INFORMATION  EXTRACTED  FROM  THE
CLEARVIEW  CINEMA  GROUP,  INC.   SEPTEMBER  30,  1997  CONSOLIDATED   FINANCIAL
STATEMENTS  AND IS  QUANTIFIED  IN ITS ENTIRETY BY  REFERENCE TO SUCH  FINANCIAL
STATEMENTS.
</LEGEND>
<CIK>                          0001038754                  
<NAME>                         CLEARVIEW CINEMA GROUP, INC.
<MULTIPLIER>                                   1
<CURRENCY>                                     U.S. DOLLARS
       
<S>                             <C>
<PERIOD-TYPE>                  9-MOS
<FISCAL-YEAR-END>                              DEC-31-1997
<PERIOD-START>                                 JAN-01-1997

<PERIOD-END>                                   SEP-30-1997
<EXCHANGE-RATE>                                1
<CASH>                                         1,196
<SECURITIES>                                   0
<RECEIVABLES>                                  0
<ALLOWANCES>                                   0
<INVENTORY>                                    78
<CURRENT-ASSETS>                               1,595
<PP&E>                                         13,514
<DEPRECIATION>                                 (1,296)
<TOTAL-ASSETS>                                 26,554
<CURRENT-LIABILITIES>                          3,745
<BONDS>                                        0
                          0
                                    0
<COMMON>                                       0
<OTHER-SE>                                     9,439
<TOTAL-LIABILITY-AND-EQUITY>                   26,554
<SALES>                                        10,630
<TOTAL-REVENUES>                               10,630
<CGS>                                          0
<TOTAL-COSTS>                                  10,396
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             1,249
<INCOME-PRETAX>                                (1,015)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            (1,015)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (1,015)
<EPS-PRIMARY>                                  (.62)
<EPS-DILUTED>                                  (.62)
        


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission